All stock reports

GENESYS evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-08T23:41:11.192829+00:00

Metrics

latest_annual_period
2026-03-31
revenue
3278089000.0
net_income
325761000.0
operating_cash_flow
102590000.0
free_cash_flow
-44372000.0
total_assets
9724282000.0
total_liabilities
2669766000.0
total_equity
7035223000.0
cash
1038824000.0
total_debt
1729384000.0
revenue_growth
0.053941160300484015
earnings_growth
-0.4205932782196673
net_margin
0.09937527626614165
roe
0.04630428914620048
debt_to_equity
0.24581793640372168
cash_conversion
0.3149241314951759
free_cash_flow_margin
-0.013535935113415163
trailing_pe
35.8
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-4921403dfd2e2a016b73b8f5c0919ea254213ae533213d0b103618e630a70a36
Policy
stock-decisions-v1
Evidence bundle hash
b1bfbd119fa428ac36da148f611f3bfaf2cff9acc5a81bee2e6bc1dde864e242
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 15a21696373f20f5698f7dc99034baa195725359c37b8c53517272a21ebc2036
  • daily-price: c0d7c5829081c397f7332c487b80ae20377232d3fa623d1e21aba9b297d8cb68
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 20-session price return was 27.96%. The cached financial metric revenue growth is 0.053941160300484015. The cached financial metric net margin is 0.09937527626614165. The cached financial metric roe is 0.04630428914620048. The cached financial metric debt to equity is 0.24581793640372168.

Risks

The trailing 60-session price return was -11.71%. The trailing 250-session price return was -44.49%. The closing price was -51.32% below its highest close in the available trailing year. The cached financial metric free cash flow margin is -0.013535935113415163. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.

Follow Up

Price source verification: REPAIRED. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Cached observations and evidence limits